We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTBI icon
2276
Community Trust Bancorp
CTBI
$1.41B
$3.06M ﹤0.01%
82,452
+577
+0.7% +$19.5K
KLRS
2277
Kalaris Therapeutics
KLRS
$96.8M
$3.05M ﹤0.01%
3,453
+171
+5% +$132K
PACK icon
2278
Ranpak Holdings
PACK
$473M
$3.05M ﹤0.01%
226,995
-3,979
-2% -$43.8K
HRTG icon
2279
Heritage Insurance Holdings
HRTG
$991M
$3.04M ﹤0.01%
299,787
-46,058
-13% -$473K
NIC icon
2280
Nicolet Bankshares
NIC
$3.62B
$3.03M ﹤0.01%
45,731
+214
+0.5% +$13.9K
TRHC
2281
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3.03M ﹤0.01%
70,737
-1,824
-3% -$69.2K
IMKTA icon
2282
Ingles Markets
IMKTA
$1.67B
$3.03M ﹤0.01%
71,023
+158
+0.2% +$6.1K
NGM
2283
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3.03M ﹤0.01%
99,980
+6,143
+7% +$134K
BLFS icon
2284
BioLife Solutions
BLFS
$1.7B
$3.01M ﹤0.01%
75,567
+14,643
+24% +$499K
RM icon
2285
Regional Management Corp
RM
$303M
$3.01M ﹤0.01%
100,924
-8,151
-7% -$202K
FRG
2286
DELISTED
Franchise Group, Inc.
FRG
$3M ﹤0.01%
98,642
-127,843
-56% -$3.38M
SCSC icon
2287
Scansource
SCSC
$1.12B
$3M ﹤0.01%
113,817
+308
+0.3% +$7.39K
BH icon
2288
Biglari Holdings Class B
BH
$1.21B
$2.99M ﹤0.01%
26,924
-667
-2% -$68.5K
FSP
2289
Franklin Street Properties
FSP
$46.8M
$2.99M ﹤0.01%
685,209
+44,118
+7% +$195K
CAC icon
2290
Camden National
CAC
$976M
$2.99M ﹤0.01%
83,573
-4,110
-5% -$141K
TGI
2291
DELISTED
Triumph Group
TGI
$2.98M ﹤0.01%
236,931
-23,039
-9% -$239K
ANIK icon
2292
Anika Therapeutics
ANIK
$287M
$2.97M ﹤0.01%
65,612
-1,864
-3% -$70.7K
ABTX
2293
DELISTED
Allegiance Bancshares
ABTX
$2.95M ﹤0.01%
86,365
-3,688
-4% -$112K
OSPN icon
2294
OneSpan
OSPN
$618M
$2.94M ﹤0.01%
142,278
-1,332
-0.9% -$28.6K
PRTS icon
2295
CarParts.com
PRTS
$54.7M
$2.94M ﹤0.01%
23,700
-653
-3% -$84.3K
SHOE
2296
Shoe Station Group
SHOE
$428M
$2.94M ﹤0.01%
149,812
+2,356
+2% +$42.1K
HY icon
2297
Hyster-Yale Materials Handling
HY
$665M
$2.91M ﹤0.01%
48,930
+3,210
+7% +$162K
CLW icon
2298
Clearwater Paper
CLW
$376M
$2.91M ﹤0.01%
77,160
-6,653
-8% -$248K
VIE
2299
DELISTED
Viela Bio, Inc. Common Stock
VIE
$2.91M ﹤0.01%
80,934
-11,651
-13% -$408K
CCF
2300
DELISTED
Chase Corporation
CCF
$2.9M ﹤0.01%
28,732
+1,290
+5% +$135K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.